The current research focuses on neurocognitive disturbances in neuro-oncology. Our previous study revealed the neurocognitive parameters of pituitary tumor patients and the change of cognitive function following surgery. We are further exploring the relationship between endocrine dysfunction and neuropsychiatric disturbance. We are also studying medulloblastoma, a common malignant pediatric brain tumor, which novel molecular markers has been shown to correlate with patient outcome.
1. 楊士弘。第四十一章 內視鏡經鼻經蝶竇腦下垂體手術。外科微創手術圖譜(ISBN:9789860411577),pp. 195-198,2014年。金名圖書有限公司。
2. Chou SC, Kuo MF, Lai DM, Chen CM, Xiao F, Tsuang FY, Yang SH. Contemporary management of pediatric spinal tumors: a single institute’s experience in Taiwan in the modern era. J Neurooncol. 2020;146:501-511.
3. Yang S.H., Kuo M.F., Yang Y.L., Huang H.Y., Peng S.F., Chen H.Y. Medulloblastoma: Application of genomic medicine for molecular classification in a taiwanese cohort. Neuro-Oncology 2018; 20 Supplement 2 (i141-).
4. Yang C.Y., Yang S.H., Yang C.C. Predictors of post-surgical quality of life in patients with non-functional pituitary adenoma: The influence of neurobehavioral functions. Neuro-Oncology 2014;16 Supplement 5 (v137).